C. Lassen

发表

A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).

A. Barbouti, M. Höglund, B. Johansson, 2002, Cancer research.

Clinical and genetic studies of ETV6/ABL1‐positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate

A. Barbouti, M. Höglund, B. Johansson, 2003, British journal of haematology.

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells

C. Lassen, T. Fioretos, M. Ehinger, 2014, Blood Cancer Journal.

Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients

B. Johansson, C. Lassen, F. Mitelman, 2004, European journal of haematology.

Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage.

C. Lassen, T. Fioretos, P. Edén, 2009, Experimental hematology.

Access to the Published Version May Require Journal Subscription. Published with Permission From: Elsevier Genetic Analysis of Chronic Myeloid Leukemia Treated with Dasatinib and Rapidly Developing Aml with Monosomy 7 in Philadelphia-negative Cells

C. Lassen, T. Fioretos, J. Richter, 2022 .

Identification of genes differentially expressed in TLS‐CHOP carrying myxoid liposarcomas

C. Lassen, N. Mandahl, P. Åman, 1999, International journal of cancer.

Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS.

M. Höglund, C. Lassen, F. Mitelman, 1996, Genomics.

Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a)

C. Lassen, T. Fioretos, U. Gullberg, 2004, Leukemia.

Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein

C. Lassen, T. Fioretos, P. Tsapogas, 2010, Proceedings of the National Academy of Sciences.

The t(X;7)(q22;q34) in paediatric T‐cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T‐cell receptor beta locus

B. Johansson, C. Lassen, T. Fioretos, 2009, British journal of haematology.

Fusion gene‐mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome

B. Johansson, C. Lassen, T. Fioretos, 2007, Genes, chromosomes & cancer.

Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region

B. Nilsson, B. Johansson, C. Lassen, 2007, Leukemia.

Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies

M. Höglund, B. Johansson, C. Lassen, 2001, Leukemia.

Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia

C. Lassen, F. Mitelman, N. Mandahl, 1997, Oncogene.

FLT3 mutations in a 10 year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns

B. Johansson, C. Lassen, T. Fioretos, 2008, Genes, chromosomes & cancer.

Deregulation of cyclin D2 by juxtaposition with T‐cell receptor alpha/delta locus in t(12;14)(p13;q11)‐positive childhood T‐cell acute lymphoblastic leukemia

B. Johansson, C. Lassen, T. Fioretos, 2006, European journal of haematology.

IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome

S. Mustjoki, C. Lassen, T. Fioretos, 2016, Leukemia.

Gene expression analysis of BCR/ABL1‐dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation

B. Nilsson, C. Lassen, T. Fioretos, 2008, Genes, chromosomes & cancer.

Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations.

Patrik Edén, Björn Nilsson, Thoas Fioretos, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma.

C. Lassen, F. Mitelman, P. Åman, 1997, Genomics.

Fusion of the BCR and the fibroblast growth factor receptor‐1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL

B Johansson, B. Johansson, C. Lassen, 2001, Genes, chromosomes & cancer.

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status

B Johansson, M Fontes, M. Höglund, 2007, Leukemia.

Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.

M. Rocchi, B. Johansson, C. Lassen, 2004, Human molecular genetics.

Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.

D. Gisselsson, C. Lassen, T. Fioretos, 2010, Blood.

Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays.

P. Meltzer, C. Lassen, T. Fioretos, 2004, Experimental hematology.

Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells

C. Lassen, T. Fioretos, U. Gullberg, 2007, Leukemia.

A methylation PCR approach for detection of fragile X syndrome

C. Lassen, P. Åman, I. Panagopoulos, 1999, Human mutation.

A novel PCR‐based approach for the detection of the Huntington disease associated trinucleotide repeat expansion

C. Lassen, P. Åman, I. Panagopoulos, 1999, Human mutation.

MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes

H. Tanke, B. Johansson, C. Lassen, 2003, Leukemia.

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations

B Johansson, M Fontes, Å. Borg, 2005, Leukemia.

Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.

C. Lassen, T. Fioretos, J. Richter, 2010, Cancer genetics and cytogenetics.

Myeloid malignancies with acquired trisomy 21 as the sole cytogenetic change are clinically highly variable and display a heterogeneous pattern of copy number alterations and mutations *

B. Johansson, C. Lassen, T. Fioretos, 2012, European journal of haematology.

Whole-exome sequencing of pediatric acute lymphoblastic leukemia

B Johansson, B. Johansson, C. Lassen, 2012, Leukemia.

Modeling Chronic Myeloid Leukemia in Immunodeficient Mice Reveals an Inflammatory State with Expansion of Aberrant Mast Cells and Accumulation of Pre B Cells

C. Lassen, T. Fioretos, M. Ehinger, 2014 .

IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome

S. Mustjoki, C. Lassen, T. Fioretos, 2016, Leukemia.

Whole-exome sequencing of pediatric acute lymphoblastic leukemia

B. Johansson, C. Lassen, F. Mitelman, 2012, Leukemia.